Certara (CERT)

• Market cap: $1.68B
• 1 day: -5.27%
• 5 days: -9.93%
• 1 month: -26.81%
• 3 months: -9.07%
• 6 months: -4.75%
• Year to date: -2.16%
• 1 year: -45.56%
• 5 years: -72.61%
• 10 years: -72.61%
• Sector: Information Technology
• Industry: Prepackaged Software

About: Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Employees: 1,546

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

2,163% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $68K

21% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 70

2% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 42

0% more funds holding in top 10

Funds holding in top 10: 2 [Q3] → 2 (+0) [Q4]

1.04% less ownership

Funds ownership: 74.34% [Q3] → 73.3% (-1.04%) [Q4]

2% less funds holding

Funds holding: 225 [Q3] → 221 (-4) [Q4]

11% less capital invested

Capital invested by funds: $1.4B [Q3] → $1.25B (-$147M) [Q4]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $13 25% upside
• Avg. target: $15 44% upside
• High target: $17 63% upside

2 analyst ratings

• positive: 1 50%
• neutral: 1 50%
• negative: 0 0%

Barclays Luke Sergott 22% 1-year accuracy 11 / 51 met price target	25% upside $13	Equal-Weight Maintained	28 Feb 2025
Stephens & Co. Jeff Garro 42% 1-year accuracy 5 / 12 met price target	63% upside $17	Overweight Reiterated	27 Feb 2025